Differential effects of a novel IFN-ζ/limitin and IFN-α on signals for Daxx induction and Crk phosphorylation that couple with growth control of megakaryocytes

Experimental Hematology

Volumn 33, Issue 4, 2005, Pages 495-503

  Ishida, Naoko ^a   Oritani, Kenji ^a,b   Shiraga, Masamichi ^a   Yoshida, Hitoshi ^a   Kawamoto, Sin Ichiro ^a   Ujiie, Hidetoshi ^a   Masaie, Hiroaki ^a   Ichii, Michiko ^a   Tomiyama, Yoshiaki ^a   Kanakura, Yuzuru ^a  

^a OSAKA UNIVERSITY   (Japan)

^b OSAKA UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA INTERFERON; ANTISENSE OLIGONUCLEOTIDE; CRK LIKE PROTEIN; CYTOKINE; DAXX PROTEIN; DYE; INTERFERON ZETA; LIMITIN; STAT1 PROTEIN; SUPPRESSOR OF CYTOKINE SIGNALING 1; UNCLASSIFIED DRUG;

ANIMAL CELL; ARTICLE; BINDING ASSAY; BIOLOGICAL ACTIVITY; CELL COUNT; CELL CULTURE; CELL DIFFERENTIATION; CELL GROWTH; CELL PROLIFERATION; CONCENTRATION (PARAMETERS); GROWTH INHIBITION; MEGAKARYOCYTE; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN ENGINEERING; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION; THROMBOCYTOPENIA; TITRIMETRY; WESTERN BLOTTING;

EID: 20144371186     PISSN: 0301472X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.exphem.2005.01.002     Document Type: Article

References (43)

1. K. Oritani, K.L. Medina, and Y. Tomiyama Limitin: An interferon-like cytokine that preferentially influences B-lymphocyte precursors Nat Med 6 2000 659 666
2. S. Kawamoto, K. Oritani, and H. Asada Antiviral activity of limitin against encephalomyocarditis virus, herpes simplex virus, and mouse hepatitis virus: diverse requirements by limitin and α interferon for interferon regulatory factor 1 J Virol 77 2003 9622 9631
3. T. Oritani, and Y. Tomiyama IFN-ζ/limitin: a novel type I interferon, which displays the narrow range of biological activities Int J Hematol 80 2004 325 331
4. I. Takahashi, H. Kosaka, and K. Oritani A new IFN-like cytokine, limitin, modulates the immune response without influencing thymocyte development J Immunol 167 2001 3156 3163
5. S. Kawamoto, K. Oritani, and E. Asakura A new interferon, limitin displays equivalent immunomodulatory and antitumor activities without myelosuppressive properties as compared with interferon-α Exp Hematol 32 2004 797 805
6. F. Wendling, and Z.C. Han Positive and negative regulation of megakaryopoiesis Bailliers Clin Haematol 10 1997 29 45
7. K. Kaushansky Thrombopoietin: the primary regulator of platelet production Blood 86 1995 419 431
8. D.J. Kuter, D.M. Gminski, and R.D. Rosenberg Transforming growth factor β inhibits megakaryocyte growth and endomitosis Blood 79 1992 619 626
9. A.M. Gewirtz, J. Zhang, and J. Ratajczak Chemokine regulation of human megakaryocytopoiesis Blood 86 1995 2559 2567
10. A. Ganser, C. Carlo-Stella, J. Greher, B. Volkers, and D. Hoelzer Effect of recombinant interferons α and γ on human bone marrow-derived megakaryocytic progenitor cells Blood 70 1987 1173 1179
11. Q. Wang, Y. Miyakawa, N. Fox, and K. Kaushansky Interferon-α directly represses megakaryopoiesis by inhibiting thrombopoietin-induced signaling through induction of SOCS-1 Blood 96 2000 2093 2099
12. K. Weiss Safety profile of interferon-α therapy Semin Oncol 25 1998 9 13
13. J.C. Mountford, S.K. Melford, C.M. Bunce, J. Gibbins, and S.P. Watson Collagen or collagen-related peptide cause (Ca2+)i elevation and increased tyrosine phosphorylation in human megakaryocytes Thromb Haemost 82 1999 1153 1159
14. P. Rojnuckarin, J.G. Drachman, and K. Kaushansky Thrombopoietin-induced activation of the mitogen-activated protein kinase (MAPK) pathway in normal megakaryocytes: role in endomitosis Blood 94 1999 1273 1282
15. M. Shiraga, A. Ritchie, and S. Aidoudi Primary megakaryocytes reveal a role for transcription factor NF-E2 in integrin α IIb β 3 signaling J Cell Biol 147 7 1999 1419 1430
16. K. Oritani, S. Hirota, and T. Nakagawa T lymphocytes constitutively produce an interferonlike cytokine limitin characterized as a heat-and acid-stable and heparin-binding glycoprotein Blood 101 2003 178 185
17. K. Shimoda, K. Kato, and K. Aoki Tyk2 plays a restricted role in IFN α signaling, although it is required for IL-12-mediated Tcell function Immunity 13 2000 561 571
18. J.E. Durbin, R. Hackenmiller, M.C. Simon, and D.E. Levy Targeted disruption of the mouse Stat1 gene results in compromised innate immunity to viral disease Cell 84 1996 443 450
19. T. Matsuyama, T. Kimura, and M. Kitagawa Targeted disruption of IRF-1 or IRF-2 results in abnormal type I IFN gene induction and aberrant lymphocyte development Cell 75 1993 83 97
20. K. Shimoda, K. Kamesaki, and A. Numata Cutting edge: tyk2 is required for the induction and nuclear translocation of Daxx which regulates IFN-α induced suppression of B lymphocyte formation J Immunol 169 2002 4707 4711
21. L.C. Platanias, and E.N. Fish Signaling pathway activated by interferons Exp Hematol 27 1999 1583 1592
22. L.C. Platanias, S. Uddin, and E. Bruno CrkL and CrkII participate in the generation of the growth inhibitory effects of interferons on primary hematopoietic progenitors Exp Hematol 27 1999 1315 1321
23. R. Gongora, R.P. Stephan, Z. Zhang, and M.D. Cooper An essential role for Daxx in the inhibition of B lymphopoiesis by type I interferons Immunity 14 2001 727 737
24. E. Jonasch, and F.G. Haluska Interferon in oncological practice: review of interferon biology, clinical applications, and toxicities The Oncologist 6 2001 34 55
25. M. Bascosi, F. Russo, and S. D'innocenzo Amantadine and interferon in the combined treatment of hepatitis C virus in elderly patients Hepatol Res 22 2002 231 239
26. K.R. Reddy, T.L. Wright, and P.J. Pockros Efficacy and safety of pegylated (40-kd) interferon α-2a compared with interferon α-2a in noncirrhotic patients with chronic hepatitis C Hepatology 33 2001 433 438
27. E.B. Melian, and G.L. Plosker Interferon alfacon-1: a review of its pharmacology and therapeutic efficacy in the treatment of chronic hepatitis C Drugs 61 2001 1661 1691
28. B. Cohen, D. Novick, S. Barak, and M. Rubinstein Ligand-induced association of the type I interferon receptor components Mol Cell Biol 15 1995 4208 4214
29. T. Improta, C. Schindler, and C.M. Horvath Transcription factor ISGF-3 formation requires phosphorylated Stat91 protein, but Stat113 protein is phosphorylated independently of Stat91 protein Proc Natl Acad Sci U S A 91 1994 4776 4780
30. S.J. Haque, and B.R. Williams Identification and characterization of an interferon (IFN)-stimulated response element-IFN-stimulated gene factor 3-independent signaling pathway for IFN-α J Biol Chem 269 1994 19523 19529
31. S. Ahmad, Y.M. Alsayed, B.J. Druker, and L.C. Platanias The type I interferon receptor mediates tyrosine phosphorylation of the CrkL adaptor protein J Biol Chem 272 1997 29991 29994
32. G. Rysiecki, D.R. Gewert, and B.R.G. Williams Constitutive expression of a 2′, 5′-oligoadenylate synthetase cDNA results in increased antiviral activity and growth suppression J Interferon Res 9 1989 649 657
33. T. Tamura, M. Ishihara, and M.S. Lamphier An IRF-1-dependent pathway of DNA damage-induced apoptosis in mitogen activated T lymphocytes Nature 376 1995 596 599
34. A. Takaoka, S. Hayakawa, and H. Yanai Integration of interferon-α/ β signaling to p53 responses in tumor suppression and antiviral defence Nature 424 2003 516 523
35. R.J. Ingham, D.L. Krebs, and S.M. Barbazuk B cell antigen receptor signaling induces the formation of complexes containing the Crk adapter proteins J Biol Chem 271 1996 32306 32314
36. K.A. Reedquist, T. Fukazawa, and G. Panchamoorthy Stimulation through the T cell receptor induces Cbl association with Crk proteins and the guanine nucleotide exchange protein C3G J Biol Chem 271 1996 8435 8442
37. S.J. Cook, B. Rubinfeld, I. Albert, and F. McCormick RapV12 antagonizes Ras-dependent activation of ERK1 and ERK2 by LPA and EGF in Rat-1 fibroblasts EMBO J 12 1993 3475 3485
38. X. Yang, R. Khosravi-Far, H.Y. Chang, and D. Baltimore Daxx, a novel Fas-binding protein that activates JNK and apoptosis Cell 89 1997 1067 1076
39. R. Li, H. Pei, D.K. Watson, and T.S. Papas EAP1/Daxx interacts with ETS1 and represses transcriptional activation of ETS1 target genes Oncogene 19 2000 745 753
40. S. Torii, D.A. Egan, R.A. Evans, and J.C. Reed Human Daxx regulates Fas-induced apoptosis from nuclear PML oncogenic domains (PODs) EMBO J 18 1999 6037 6049
41. P. Salomoni, and P.P. Pandolfi The role of PML in tumor suppression Cell 108 2002 165 170
42. S.M.R. Rani, G.R. Foster, and S. Leung Characterization of β-R1, a gene that is selectively induced by interferon-β (IFN-β) compared with IFN-α J Biol Chem 271 1996 22878 22884
43. C. Abramovich, L.M. Shulman, and E. Ratovistski Differential tyrosine phosphorylation of the IFNAR chain of the type I interferon receptor and an associated surface protein in response to IFN α and IFN β EMBO J 13 1994 5871 5877